MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
Intricacies and misconceptions of Frontal Lobe Epilepsy

Intricacies and misconceptions of Frontal Lobe Epilepsy

by MEGIN | Feb 22, 2022 | Masterclass - Basic Research

MEGIN Masterclass Intricacies and misconceptions of Frontal Lobe Epilepsy Presented by Dr. Saleem Malik. Abstract: This masterclass presented by Dr. Saleem Malik, “will address the exquisite intricacies of frontal lobe epilepsy, which often can be misdiagnosed...
Understanding how pre- and post-natal exposures influence brain development using MEG

Understanding how pre- and post-natal exposures influence brain development using MEG

by MEGIN | Nov 30, 2021 | Masterclass - Basic Research

MEGIN Masterclass Understanding how pre- and post-natal exposures influence brain development using MEG Presented by Dr. Julia Stephen. Abstract: “The brain develops rapidly throughout gestation and childhood. However, little is known about how pre- and...
Functional networks impairment along the process of AD: prediction value and resilience factors

Functional networks impairment along the process of AD: prediction value and resilience factors

by MEGIN | Sep 29, 2021 | Masterclass - Basic Research

MEGIN Masterclass Functional networks impairment along the process of AD: prediction value and resilience factors Presented by Fernando Maestú. Abstract: Fernando Maestú discusses a series of studies, which mainly used MEG to record the resting-state activity and a...
Next Entries »

Home
About us

MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.